Trigeminal neuropathy is damage to the trigeminal nerve, the large nerve responsible for sensation across your face. Unlike trigeminal neuralgia, which causes sudden, shock-like pain attacks, trigeminal neuropathy typically produces continuous burning or squeezing pain along with numbness and altered sensation. It can affect one or both sides of the face and sometimes appears as the first sign of an underlying condition like an autoimmune disease or tumor.
How It Differs From Trigeminal Neuralgia
The two conditions are often confused, but they feel different and behave differently. Trigeminal neuralgia is defined by brief, intense jolts of pain, often triggered by light touch to a small area of the face. Trigeminal neuropathy produces a more constant background pain, commonly described as burning, squeezing, or a pins-and-needles sensation. Sharp pain episodes can happen on top of this baseline discomfort, but they aren’t the main feature.
The other key distinction is sensory loss. Numbness is present in about 51% of people with post-traumatic trigeminal neuropathy, compared to only 12% of those with trigeminal neuralgia. In trigeminal neuropathy, areas of heightened sensitivity to touch or cold (called allodynia and hyperalgesia) tend to be spread across a broad zone. In trigeminal neuralgia, trigger zones are typically small, pinpoint areas. Both conditions carry a significant psychological burden: clinically meaningful anxiety affects roughly 34% to 39% of patients in either group, and depression trends higher in trigeminal neuralgia but is common in both.
What Causes It
The causes fall into three broad categories: trauma, tumors, and autoimmune or inflammatory disease.
Trauma is the single most common cause, responsible for up to 40% of cases. Dental procedures are a frequent culprit, particularly wisdom tooth extractions, nerve block injections, and dental implant placement. When a dental implant compresses or damages the nerve running through the lower jaw, the result can be persistent pain and numbness in the lip and chin. One study of over 1,000 implant placements found that about 0.8% of patients developed trigeminal neuropathy afterward. Blunt or penetrating head injuries can also damage the nerve, especially along the cheek and upper jaw region.
Tumors account for another important subset. Growths can compress the nerve at various points along its path, from deep inside the brain to the bones of the skull and face. Cancers of the lung, breast, head and neck, and non-Hodgkin’s lymphoma can spread to areas near the trigeminal nerve. In some cases, trigeminal neuropathy is the first symptom that leads to the discovery of a tumor, which is why new, unexplained facial numbness always warrants investigation.
Autoimmune and connective tissue diseases are a third major cause. Mixed connective tissue disease is the most strongly associated: trigeminal neuropathy is its most common neurological complication, and roughly 10% to 17% of these patients develop some form of neuropsychiatric problem. In systemic sclerosis (scleroderma), about 4% of patients develop trigeminal neuropathy. Sjögren’s syndrome is notable because nerve involvement can appear before the hallmark dry eyes and dry mouth, sometimes by years. In one Japanese study, trigeminal neuropathy was the most frequent neurological finding in Sjögren’s patients, affecting half of those with documented nerve abnormalities. Multiple sclerosis and sarcoidosis can also cause it, though they rarely present as isolated facial numbness alone.
The mechanism in autoimmune disease likely involves inflammation of the tiny blood vessels supplying the nerve, immune complex deposits along the nerve root, and progressive scarring of the nerve’s protective layers. This scarring increases pressure within the nerve and selectively damages the fibers that carry sensation.
Symptoms and Where They Occur
The trigeminal nerve has three branches. The first covers the forehead and upper eye area, the second covers the cheek and upper jaw, and the third covers the lower jaw, chin, and lower lip. Trigeminal neuropathy can affect one branch, multiple branches, or all three, and it can occur on one side or both sides of the face.
The hallmark symptom is slowly developing facial numbness. Many people also experience pain and tingling (paresthesia), and taste disturbance is common when the lower branch is involved. The numbness can range from a subtle feeling that your face is “different” to a complete loss of sensation in the affected area. Touching the skin may feel unpleasant or even painful, especially with light brushing or cold temperatures. Eating, shaving, or applying makeup can become uncomfortable because everyday contact with the face triggers disproportionate discomfort.
How It’s Diagnosed
Diagnosis starts with a detailed history and a physical exam focused on mapping where sensation is reduced or altered. Simple bedside tests like light touch with a cotton wisp, pinprick, and temperature testing help outline which branches are affected. Quantitative sensory testing, a more precise tool that measures exact thresholds for detecting touch, pressure, warmth, and cold, can confirm and track nerve damage over time. It has proven useful in identifying nerve injuries after dental procedures, in burning mouth syndrome, and in cases where symptoms are subtle.
Imaging plays a critical role, especially to rule out tumors or structural compression. MRI of the brain and the nerve’s path through the skull is standard. Blood work may be ordered to check for autoimmune markers, particularly if no clear trauma or structural cause is found. High levels of certain antibodies, such as those targeting ribonucleoprotein RNA, can point toward mixed connective tissue disease as the underlying driver.
Treatment Options
Treatment depends on whether the neuropathy is caused by something reversible, like a compressive implant that can be removed, or something chronic that needs long-term pain management.
For neuropathic pain, medications originally developed for seizures are the mainstay. Carbamazepine and oxcarbazepine are first-line options. These work by calming the overactive nerve signals responsible for pain. If they don’t provide enough relief or cause intolerable side effects like drowsiness or dizziness, second-line options include lamotrigine and baclofen. The evidence behind second-line drugs is thinner, with each supported by only a single clinical trial, but they can help when first-line treatments fall short. Baclofen is sometimes combined with carbamazepine for added benefit.
When the cause is an autoimmune disease, treating the underlying condition with immunosuppressive therapy can improve or stabilize nerve function. If a tumor is compressing the nerve, treating the tumor (through surgery, radiation, or chemotherapy) is the priority.
Surgical options exist for select cases. When there’s clear evidence of a blood vessel pressing on the nerve, microvascular decompression can relieve the pressure. If no compressing vessel is found, procedures like partial sensory rhizotomy or internal neurolysis (sometimes called nerve combing) may be considered to reduce pain signals. Factors associated with better surgical outcomes include confirmed nerve compression, the presence of specific trigger points, shorter disease duration, and the absence of venous (as opposed to arterial) compression.
Recovery and Long-Term Outlook
The prognosis for trigeminal neuropathy depends heavily on the cause and the severity of nerve damage. When the injury is mild, such as minor bruising of the nerve during a dental procedure, some degree of spontaneous recovery may occur within the first several months. However, if significant improvement hasn’t happened by 6 to 9 months after injury, some level of permanent sensory change is likely. Complete recovery is uncommon across all currently available treatments.
For people with autoimmune-related trigeminal neuropathy, the condition often follows a slowly progressive course unless the underlying disease is controlled. Numbness may worsen or spread to additional branches of the nerve over time. For post-traumatic cases, early recognition matters: the sooner the cause is identified and addressed, the better the chance of limiting permanent damage. Living with chronic facial numbness or pain often requires a combination of medication, coping strategies, and periodic reassessment to adjust treatment as symptoms evolve.